Results 1 to 10 of about 11,782,455 (235)

Can Pharmacologic Therapy Induce Histologic Improvement in Non-alcoholic Steatohepatitis?

open access: yesThe Korean Journal of Gastroenterology, 2016
Articles: Farnesoid X Nuclear Receptor Ligand Obeticholic Acid for Non-cirrhotic, Non-alcoholic Steatohepatitis (FLINT): a Multicentre, Randomised, Placebo-controlled Trial (Lancet 2015;385:956-965) Liraglutide Safety and Efficacy in Patients with Non ...
Nae-Yun Heo
doaj   +2 more sources

Сomparative Study of Progepar Efficacy in Patients with Non-Alcoholic Steatohepatitis

open access: yesGastroenterologìa, 2015
Non-alcoholic fatty liver disease is one of the most common pathologies of the liver in developed countries. On the average, its prevalence reaches 20 %.
V.G. Perederii, G.K. Syzenko
doaj   +2 more sources

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2023
Background. The urgency of the problem of comorbidity of alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH) with anaemic conditions and the need for their differentiated correction is determined by the significant frequency of these
T. Antofiichuk   +3 more
doaj   +1 more source

Correlation of serum aspartate aminotransferase level to platelet count ratio index with non-alcoholic fatty liver disease activity score

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2019
In case of non-alcoholic fatty liver disease, the ratio of serum aspartate  aminotransferase (AST) level to platelet count index has been proposed as a non-invasive and readily available tool for the assessment of non-alcoholic steatohepatitis. The study
Dulal Chandra Das   +5 more
doaj   +1 more source

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS [PDF]

open access: yesRomanian Medical Journal, 2018
Non-alcoholic fatty liver comprises several clinical entities, starting from hepatic steatosis and reaching steatohepatitis, fibrosis and liver cirrhosis; it is currently considered a major public health issue.
Anca Smaranda Farmazon   +6 more
doaj   +1 more source

Treatments for NAFLD [PDF]

open access: yesFarmacja Polska, 2021
Non-alcoholic fatty liver disease (NAFLD) is categorised into simple steatosis, termed nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH).
Katarzyna Juszczyńska
doaj   +1 more source

Diagnosis of Non-alcoholic fatty liver disease

open access: yesJournal of Pathology of Nepal, 2016
Non Alcoholic Fatty Liver Disease is the deposition of fat in liver in absence of excessive of alcohol consumption. Non Alcoholic Fatty Liver Disease ranges from simple steatosis to Nonalcoholic steatohepatitis and cirrhosis.
Geetika K.C.
doaj   +1 more source

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis

open access: yesJournal of Education, Health and Sport, 2021
The retrospective analysis of 378 medical records of inpatients with steatohepatitis (SH) depending on its etiology was performed to identify and study the type of anaemic conditions (AC).
Oksana Khukhlina   +2 more
doaj   +1 more source

Non-alcoholic steatohepatitis

open access: yesEuropean Journal of Gastroenterology & Hepatology, 2004
Non-alcoholic steatohepatitis (NASH) is an underdiagnosed liver disease characterized by steatosis, necroinflammation and fibrosis. This disease may eventually develop into cirrhosis and hepatocellular carcinoma. NASH is highly prevalent among obese individuals and among patients with diabetes mellitus type 2.
R, Vecchione   +3 more
openaire   +5 more sources

P-57 LIVER STEATOSIS AND STEATOHEPATITIS IN LIVER DISEASES OTHER THAN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER

open access: yesAnnals of Hepatology, 2021
Introduction: Fatty liver disease (FLD) alcoholic and non-alcoholic are prevalent conditions. The damage is determined by steatosis and steatohepatitis with or without fibrosis.
Ana Jiménez   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy